Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Home intravenous antibiotic therapy.

B E Scully1

  • 1College of Physicians and Surgeons of Columbia University, New York, NY.

New Jersey Medicine : the Journal of the Medical Society of New Jersey
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Periumbilical parasitic thumbprint purpura: strongyloides hyperinfection syndrome acquired from a cadaveric renal transplant.

Transplant infectious disease : an official journal of the Transplantation Society·2010
Same author

Infections during left ventricular assist device support do not affect posttransplant outcomes.

Circulation·2000
Same author

The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·1997
Same author

Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1993
Same author

Mupirocin treatment of nasal staphylococcal colonization.

Archives of internal medicine·1992
Same author

Bactericidal activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae and streptococcal pathogens.

Journal of clinical pharmacology·1991
Same journal

Putting the public back in the public health.

New Jersey medicine : the journal of the Medical Society of New Jersey·2005
Same journal

Computer as consultants.

New Jersey medicine : the journal of the Medical Society of New Jersey·2005
Same journal

Epilepsy in pregnancy.

New Jersey medicine : the journal of the Medical Society of New Jersey·2005
Same journal

New regulation for prescriptions.

New Jersey medicine : the journal of the Medical Society of New Jersey·2005
Same journal

Paradise lost: the high cost of infertility.

New Jersey medicine : the journal of the Medical Society of New Jersey·2005
Same journal

Julie Goldman. The New Jersey medicine interview. Interview by Bill Berlin.

New Jersey medicine : the journal of the Medical Society of New Jersey·2005
See all related articles

Home intravenous therapy is safe and cost-effective for various infections. Close patient monitoring is crucial, and more infections will be treatable at home in the future.

Area of Science:

  • Infectious Diseases
  • Healthcare Management
  • Patient Care

Background:

  • Intravenous (IV) therapy is a common treatment for various infections.
  • Home-based healthcare offers potential benefits in terms of cost and patient convenience.
  • The feasibility and safety of home IV therapy require careful consideration.

Purpose of the Study:

  • To evaluate the safety and cost-effectiveness of home-based intravenous therapy for infections.
  • To highlight the importance of patient monitoring in home IV therapy settings.
  • To project the future expansion of home-treatable infections.

Main Methods:

  • Review of existing literature on home IV therapy outcomes.
  • Analysis of cost-effectiveness data comparing home vs. hospital settings.

Related Experiment Videos

  • Assessment of patient monitoring protocols in home care.

    • Main Results:

    • Home intravenous therapy is demonstrated to be safe and cost-effective for managing a range of infections.
    • Effective patient monitoring is identified as a critical factor for successful home IV therapy.
    • The scope of infections treatable in the home setting is expected to grow.

    Conclusions:

    • Home-based IV therapy presents a viable and economical alternative for infection management.
    • Robust patient monitoring systems are essential for ensuring the quality and safety of home IV treatments.
    • The trend towards increasing home-based infection treatment is likely to continue, expanding healthcare options.